The first Haemonetics trade was made in Q2 2013.
Since then Jim Simons bought shares 24 more times and sold shares on 22 occasions. The investor completely sold their stake between Q3 2024 and Q4 2024.
Avg closing price
Price range
Sold -42 Thousand shares
Q4 2024
Avg closing price
$80.28
Price range
$71.16
-
$93.38
Sold 24.3% shares (-13.5 Thousand shares)
Q3 2024
Avg closing price
$80.76
Price range
$72.45
-
$91.58
New holding (+55.5 Thousand shares)
Q2 2024
Avg closing price
$87.97
Price range
$81.24
-
$97.37
Sold -38.5 Thousand shares
Q1 2024
Avg closing price
$78.48
Price range
$71.24
-
$85.35
Sold 72.9% shares (-104 Thousand shares)
Q4 2023
Avg closing price
$86.45
Price range
$80.59
-
$92.61
Increased shares by 99.3% (+70.9 Thousand shares)
Q3 2023
Avg closing price
$89.28
Price range
$82.56
-
$93.49
Increased shares by 1273.1% (+66.2 Thousand shares)
Q2 2023
Avg closing price
$84.55
Price range
$80.84
-
$89.45
Increased shares by 62.5% (+2 Thousand shares)
Q1 2023
Avg closing price
$80.95
Price range
$72.75
-
$90.60
New holding (+3.2 Thousand shares)
Q4 2022
Avg closing price
$80.38
Price range
$74.55
-
$86.14
Sold -40.1 Thousand shares
Q3 2022
Avg closing price
$71.80
Price range
$63.30
-
$78.66
Increased shares by 81.4% (+18 Thousand shares)
Q2 2022
Avg closing price
$59.18
Price range
$49.27
-
$66.08
New holding (+22.1 Thousand shares)
Q1 2022
Avg closing price
$54.38
Price range
$43.77
-
$63.22
Sold -130 Thousand shares
Q4 2021
Avg closing price
$60.93
Price range
$49.55
-
$74.59
Sold 78.4% shares (-471 Thousand shares)
Q3 2021
Avg closing price
$63.10
Price range
$57.60
-
$70.59
Sold 53.1% shares (-680 Thousand shares)
Q2 2021
Avg closing price
$70.76
Price range
$51.81
-
$118.56
Sold 18.8% shares (-296 Thousand shares)
Q1 2021
Avg closing price
$123.75
Price range
$111.01
-
$139.48
Sold 18.5% shares (-358 Thousand shares)
Q4 2020
Avg closing price
$107.66
Price range
$88.75
-
$119.95
Sold 11.6% shares (-254 Thousand shares)
Q3 2020
Avg closing price
$87.39
Price range
$75.65
-
$93.58
Increased shares by 0.2% (+3.4 Thousand shares)
Q2 2020